219 related articles for article (PubMed ID: 9448324)
21. The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors.
de Launoit Y; Audette M; Pelczar H; Plaza S; Baert JL
Oncogene; 1998 Apr; 16(16):2065-73. PubMed ID: 9572487
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.
Castillo AI; Tolon RM; Aranda A
Oncogene; 1998 Apr; 16(15):1981-91. PubMed ID: 9591782
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
[TBL] [Abstract][Full Text] [Related]
24. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
Hagman J; Grosschedl R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
[TBL] [Abstract][Full Text] [Related]
25. Identification of a placental-specific enhancer in the rat placental lactogen II gene that contains binding sites for members of the Ets and AP-1 (activator protein 1) families of transcription factors.
Sun Y; Duckworth ML
Mol Endocrinol; 1999 Mar; 13(3):385-99. PubMed ID: 10076996
[TBL] [Abstract][Full Text] [Related]
26. Expression of mutant Ets protein at the neuromuscular synapse causes alterations in morphology and gene expression.
de Kerchove D'Exaerde A; Cartaud J; Ravel-Chapuis A; Seroz T; Pasteau F; Angus LM; Jasmin BJ; Changeux JP; Schaeffer L
EMBO Rep; 2002 Nov; 3(11):1075-81. PubMed ID: 12393756
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
[TBL] [Abstract][Full Text] [Related]
28. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
29. Regulation of interferon-tau (IFN-tau) gene promoters by growth factors that target the Ets-2 composite enhancer: a possible model for maternal control of IFN-tau production by the conceptus during early pregnancy.
Ezashi T; Roberts RM
Endocrinology; 2004 Oct; 145(10):4452-60. PubMed ID: 15217985
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the acetylcholine receptor epsilon subunit gene by recombinant ARIA: an in vitro model for transynaptic gene regulation.
Chu GC; Moscoso LM; Sliwkowski MX; Merlie JP
Neuron; 1995 Feb; 14(2):329-39. PubMed ID: 7857642
[TBL] [Abstract][Full Text] [Related]
31. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
[TBL] [Abstract][Full Text] [Related]
32. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
[TBL] [Abstract][Full Text] [Related]
33. Signal transduction and the Ets family of transcription factors.
Yordy JS; Muise-Helmericks RC
Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
[TBL] [Abstract][Full Text] [Related]
34. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression.
Langer SJ; Bortner DM; Roussel MF; Sherr CJ; Ostrowski MC
Mol Cell Biol; 1992 Dec; 12(12):5355-62. PubMed ID: 1448070
[TBL] [Abstract][Full Text] [Related]
35. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.
Patton SE; Martin ML; Nelsen LL; Fang X; Mills GB; Bast RC; Ostrowski MC
Cancer Res; 1998 May; 58(10):2253-9. PubMed ID: 9605774
[TBL] [Abstract][Full Text] [Related]
36. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex.
Butticè G; Duterque-Coquillaud M; Basuyaux JP; Carrère S; Kurkinen M; Stéhelin D
Oncogene; 1996 Dec; 13(11):2297-306. PubMed ID: 8957070
[TBL] [Abstract][Full Text] [Related]
37. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1.
McNagny KM; Sieweke MH; Döderlein G; Graf T; Nerlov C
EMBO J; 1998 Jul; 17(13):3669-80. PubMed ID: 9649437
[TBL] [Abstract][Full Text] [Related]
38. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products.
Chen L; Zhang W; Fregien N; Pierce M
Oncogene; 1998 Oct; 17(16):2087-93. PubMed ID: 9798679
[TBL] [Abstract][Full Text] [Related]
39. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
40. Neuregulin-1-stimulated phosphorylation of GABP in skeletal muscle cells.
Fromm L; Burden SJ
Biochemistry; 2001 May; 40(17):5306-12. PubMed ID: 11318655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
